RVMDRevolution MedicinesHealth Care
$157.48EarningsAug 5, 2026
1D—1W—1M—3M—1Y—
Market cap$31.2BCompany infoRevenue$0.0052-wk range$35 – $193IndustryBiotechnologyWebsiterevmed.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +293.4% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S———
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin———
Operating margin———
Net margin———
ROE-79.1%13
-79%
-21%
ROIC-66.1%13
-66%
-17%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.108575
0.0
0.1
Net debt / EBITDA———
Current ratio6.809596
Interest coverage-39.0×13
Per shareTTM, with year-over-year change
Revenue / share$0.00—
EPS (diluted)$-7.11▼ −77%
FCF / share$-5.41▼ −78%
Est. EPS growth (fwd)—